Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("pharmacovigilance")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 6197

  • Page / 248
Export

Selection :

  • and

A brief primer on automated signal detectionHAUBEN, Manfred.The Annals of pharmacotherapy. 2003, Vol 37, Num 7-8, pp 1117-1123, issn 1060-0280, 7 p.Article

LA PHARMACOVIGILANCE VÉTÉRINAIRE : OBJECTIFS, MISSIONS, MISE EN ŒUVRE ET RÉSULTATS = VETERINARY PHARMACOVIGILANCE : OBJECTIVES, MISSIONS, IMPLEMENTATION, AND RESULTSENRIQUEZ, Brigitte.Bulletin de l'Académie vétérinaire de France. 2008, Vol 161, Num 1, pp 35-40, issn 0001-4192, 6 p.Article

Monitoring product safety in the postmarketing environmentSHARRAR, Robert G; DIECK, Gretchen S.Therapeutic advances in drug safety (Print). 2013, Vol 4, Num 5, pp 211-219, issn 2042-0986, 9 p.Article

The challenge of biosimilarsMELLSTEDT, H; NIEDERWIESER, D; LUDWIG, H et al.Annals of oncology. 2008, Vol 19, Num 3, pp 411-419, issn 0923-7534, 9 p.Article

Ethical considerations in post-market-approval monitoring and regulation of vaccines regulation of vaccines : Vaccination EthicsTHOMPSON, Alison; KOMPARIC, Ana; SMITH, Maxwell J et al.Vaccine. 2014, Vol 32, Num 52, pp 7171-7174, issn 0264-410X, 4 p.Article

Pharmacovigilance = Pharmacovigilance updateLIVIO, F; BIOLLAZ, J; BUCLIN, T et al.Revue médicale suisse. 2011, Vol 7, Num 277, pp 71-74, issn 1660-9379, 4 p.Article

Pharmacovigilance et tératovigilance = Pharmacovigilance and teratovigilanceLIVIO, F; BUCLIN, T; BIOLLAZ, J et al.Revue médicale suisse. 2007, Vol 3, Num 95, pp 238-242, issn 1660-9379, 5 p.Article

Pharmacovigilance : NOUVEAUTES EN MEDECINE 2011 (DEUXIEME PARTIE) = PharmacovigilanceLIVIO, F; RENARD, D; BUCLIN, T et al.Revue médicale suisse. 2012, Vol 8, Num 324, pp 116-119, issn 1660-9379, 4 p.Article

The importance of direct patient reporting of suspected adverse drug reactions: a patient perspectiveANDERSON, Claire; KRSKA, Janet; MURPHY, Elizabeth et al.British journal of clinical pharmacology. 2011, Vol 72, Num 5, pp 806-822, issn 0306-5251, 17 p.Article

PharmacovigilanceIMBS, Jean-Louis.La Revue du praticien. Médecine générale. 2007, Num 790, pp 1139-1144, issn 0989-2737, 6 p.Article

VigilanceLa Revue Prescrire. 2004, Vol 24, Num 250, issn 0247-7750, p. 349Article

A new model of pharmacovigilance? A pilot studyZANCAN, A; LOCATELLI, C; RAMELLA, F et al.Biomedicine & pharmacotherapy. 2009, Vol 63, Num 6, pp 451-455, issn 0753-3322, 5 p.Article

Strategies for Developing Pharmacovigilance. ISoP Annual MeetingDrug safety. 2008, Vol 31, Num 10, pp 885-960, issn 0114-5916, 75 p.Conference Paper

Collaboration entre l'Observatoire dédié au cancer et les Centres régionaux de pharmacovigilance: premiers résultats sur la pharmacovigilance: des médicaments anticancéreux = Observatory dedicated to cancer and CRPV collaboration: first results in pharmacovigilance of innovative cancer drugsRUELLAN, A. L; BELLISSANT, E; RICHE, C et al.La Lettre du pharmacologue (Boulogne). 2013, Vol 27, Num 2, pp 51-57, issn 0984-452X, 7 p.Article

The Renaissance of PharmacovigilanceDrug safety. 2013, Vol 36, Num 9, pp 793-951, issn 0114-5916, 159 p.Conference Paper

MEDIATOR : un médicament au coeur de l'actualitéWILT, Catherine.2012, 139 p.Thesis

The future of pharmacovigilance : a personal viewEDWARDS, I. Ralph.European journal of clinical pharmacology. 2008, Vol 64, Num 2, pp 173-181, issn 0031-6970, 9 p.Article

Pharmacovigilance Using Clinical NotesLEPENDU, P; IYER, S. V; BAUER-MEHREN, A et al.Clinical pharmacology and therapeutics. 2013, Vol 93, Num 6, pp 547-555, issn 0009-9236, 9 p.Article

Online Reporting of Adverse Drug Reactions: A Study from a French Regional Pharmacovigilance CenterABADIE, Delphine; CHEBANE, Leyla; BERT, Max et al.Thérapie (Paris). 2014, Vol 69, Num 5, pp 395-400, issn 0040-5957, 6 p.Article

Pharmacovigilance : Nouveautés en médecine 2007 (Deuxième partie) = Pharmacovigilance UpdateLIVIO, F; BUCLIN, T; BIOLLAZ, J et al.Revue médicale suisse. 2008, Vol 4, Num 140, pp 150-154, issn 1660-9379, 5 p.Article

Congrès annuel de la Société Française de PharmacologieThérapie (Paris). 1998, Vol 53, Num 2, pp 169-196, issn 0040-5957Conference Proceedings

Le point sur la pharmacovigilanceCAHIERS HOSPITALIERS. 1995, Num 108, pp 9-10, issn 0295-4591Article

Off-Label PharmacovigilanceRALPH EDWARDS, I.Drug safety. 2011, Vol 34, Num 10, pp 795-797, issn 0114-5916, 3 p.Article

AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting SystemGRIGORIEV, Igor; ZU CASTELL, Wolfgang; TSVETKOV, Philipp et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 8, pp 795-801, issn 1053-8569, 7 p.Article

Drugs and Cancer: an Analysis of the French Pharmacovigilance DatabaseDURRIEU, Geneviève; MAZAU, Benjamin; JEGU, Jérémi et al.Thérapie (Paris). 2013, Vol 68, Num 3, pp 149-154, issn 0040-5957, 6 p.Article

  • Page / 248